Kaisernetwork.org is no longer publishing new content as of June 1, 2009.

The Kaiser Family Foundation continues to provide webcasts, podcasts and transcripts of Kaiser's events along with health policy briefings on the Hill conducted by the Alliance for Health Reform. You may access these webcasts, along with Kaiser's original videos and documentaries, on kff.org. All archived webcasts, podcasts and transcripts made available on kaisernetwork.org prior to June 1, 2009, continue to be available on-demand. You may search for webcasts here.

Ask the Experts: Drug Reimportation 12/2/2003 Kaiser Family Foundation Broadcast Studio, Washington, D.C. Other Related Links      ------------------- U.S. Government Resources Publications and Reports Publications and Reports "The Grim Economics of Pharmaceutical Importation" American Enterprise Institute, October 31, 2003 "The High Price of Cheap Drugs" This issue brief by John E. Calfee discusses drug reimportation legislation and suggests passage of this legislation would mean importing foreign price controls, which would destroy the pricing structure of the U.S. drug market and have disastrous consequences for future drug research and development. American Enterprise Institute (AEI), July 2003 "Prescription Drug Costs and the Role of Generic Drugs: Public Opinion Among Americans Aged 45 and Over" This nationally representative telephone survey of 1,046 Americans age 45 and over explores public opinion surrounding this legislation, prescription drug prices, and the continuing importance of a Medicare drug benefit bill. AARP, October 2002 "Federal Policies Affecting The Cost and Availability of New Pharmaceuticals" This report by Michael Gluck of the Georgetown University Institute for Health Care Research and Policy examines several ways in which the federal government influences the availability and cost of prescription drugs. Kaiser Family Foundation, July 2002 "A Primer: Generic Drugs, Patents and the Pharmaceutical Marketplace" This report discusses topics including the basics of Hatch-Waxman, the Orange book, and state laws on generic subsitution. National Institute for Health Care Management, June 2002 "Changing Patterns in Pharmaceutical Innovation" The study finds that prescription drugs have provided some of the most important recent medical advances, but that the variance in innovation makes quantifying the benefits and costs of new drug innovation difficult. National Institute for Health Care Management, May 2002 Kaiser Family Foundation: Prescription Drug Discount Card Programs: Implications for Medicare Beneficiaries This testimony was delivered by Tricia Neuman, a vice president of the Kaiser Family Foundation, at a Senate Finance Committee hearing on the Bush Administration's Proposals for Medicare Modernization. Kaiser Family Foundation, March 7, 2002 "Prescription Drug Reimportation: Panacea or Problem?" Article examines the potential effects of prescription drug reimportation. Managed Care, December 2000 "How Increased Competition from Generic Drugs Has Affected Prices Prices and Returns in the Pharmaceutical Industry" This study examines the extent to which competition from generic drugs has increased since the act. It also analyzes how that competition has affected the returns from developing a drug. Congressional Budget Office, July 1998 Return to HealthCast ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... About Us     Help